Moreover, the five oxidized sterols activated LXRs without inducing SREBP1c-mediated lipogenesis in hepatocytes, these compounds may have the potential to prevent or delay the progression of Alzheimer’s disease, other neurodegenerative diseases and cardiovascular diseases since their effect is not accompanied by undesirable adverse hepatic effects. The gene discussed is SREBF1; the disease is cardiovascular disorder.